Skip to main content
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1999 Nov;24(5):453–455.

The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.

S M Dursun 1, A Szemis 1, H Andrews 1, M A Reveley 1
PMCID: PMC1189059  PMID: 10586536

Abstract

OBJECTIVE: To investigate the effects of 12 weeks of clozapine treatment on levels of cholesterol and related lipids in patients with schizophrenia. DESIGN: Prospective study. SETTING: University department associated with a teaching hospital. PARTICIPANTS: Eight patients (6 women and 2 men) with a clinical diagnosis of schizophrenia consistent with DSM-IV criteria. The patients were classified as treatment-resistant and had not responded to treatment with at least 2 conventional antipsychotics. INTERVENTIONS: Current antipsychotic medications were tapered and treatment with clozapine was initiated. OUTCOME MEASURES: Cholesterol and serum lipid levels, as well as Brief Psychiatric Rating Scale (BPRS) scores were measured before and after 12 weeks of treatment with clozapine. RESULTS: Clozapine treatment significantly improved the BPRS scores but did not significantly alter serum lipid levels, except triglyceride levels, which increased. CONCLUSION: The previously reported lower levels of cholesterol in treatment-resistant patients with schizophrenia cannot be attributed to the effects of clozapine administration. Further research is required to support and clarify the effects of antipsychotic drugs on lipid levels.

Full text

PDF
453

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boston P. F., Dursun S. M., Zafar R., Reveley M. A. Serum cholesterol and treatment-resistance in schizophrenia. Biol Psychiatry. 1996 Sep 15;40(6):542–543. doi: 10.1016/0006-3223(96)00102-3. [DOI] [PubMed] [Google Scholar]
  2. Ghaeli P., Dufresne R. L. Serum triglyceride levels in patients treated with clozapine. Am J Health Syst Pharm. 1996 Sep 1;53(17):2079–2081. doi: 10.1093/ajhp/53.17.2079. [DOI] [PubMed] [Google Scholar]
  3. Hawthon K., Cowen P., Owens D., Bond A., Elliott M. Low serum cholesterol and suicide. Br J Psychiatry. 1993 Jun;162:818–825. doi: 10.1192/bjp.162.6.818. [DOI] [PubMed] [Google Scholar]
  4. Kahn R. S., Davidson M., Siever L., Gabriel S., Apter S., Davis K. L. Serotonin function and treatment response to clozapine in schizophrenic patients. Am J Psychiatry. 1993 Sep;150(9):1337–1342. doi: 10.1176/ajp.150.9.1337. [DOI] [PubMed] [Google Scholar]
  5. Muldoon M. F., Kaplan J. R., Manuck S. B., Mann J. J. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry. 1992 Apr 1;31(7):739–742. doi: 10.1016/0006-3223(92)90285-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES